Us Pharma Companies
- All
- News
- Videos
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Warns Pharma Companies To Cut Prices Or Be Punished
US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
US Pharma Giant Johnson & Johnson To Split Into 2 Companies
US pharmaceutical giant Johnson & Johnson on Friday announced plans to break up into two entities, turning its consumer health arm into a separate company.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
US Pharma Firm HDT Bio Begins Phase III Trial Of Covid Vaccine In India
US-based bio-pharmaceutical company HDT Bio Corp on Wednesday announced the start of Phase III trial of its COVID-19 vaccine in India.
-
India Reaches Out To US Companies Over Investment In Pharma Sector
India has reached out to top American pharma companies seeking investment in the country's pharmaceutical and medical devices sector, which gains urgency in view of a devastating second wave of the coronavirus pandemic.
-
"UK Marks A Historic Moment In Fight Against Covid-19": Pfizer CEO
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
Snowflake IPO Raises $3.36 Billion in Year's Biggest US Listing
Snowflake said that its initial public offering raised $3.36 billion (roughly Rs. 24,711 crores) after it was priced above the target range in the biggest US listing so far this year.
-
US Pharma Firm Gilead To Make 2 Million Courses Of Remdesivir By 2020 End
Gilead Sciences Inc is planning to make more than two million courses of its potential COVID-19 drug remdesivir by the end of the year and start trials of an easier-to-use inhaled version in August, the company said on Monday.
-
US Company Signs $87 Million Coronavirus Vaccine Deal With UK Pharma Firm
Emergent BioSolutions Inc said on Thursday it signed an $87 million deal to make AstraZeneca Plc's experimental COVID-19 vaccine in the United States, boosting the British drugmaker's efforts to bring a vaccine to the market.
-
US Pharma Firm Says Its COVID-19 Vaccine Produces Antibodies In Mice, Guinea Pigs
US immunotherapy company Inovio Pharmaceuticals Inc on Wednesday said its experimental vaccine to prevent coronavirus infection was shown to produce protective antibodies and immune system responses in mice and guinea pigs.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Warns Pharma Companies To Cut Prices Or Be Punished
US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
US Pharma Giant Johnson & Johnson To Split Into 2 Companies
US pharmaceutical giant Johnson & Johnson on Friday announced plans to break up into two entities, turning its consumer health arm into a separate company.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
US Pharma Firm HDT Bio Begins Phase III Trial Of Covid Vaccine In India
US-based bio-pharmaceutical company HDT Bio Corp on Wednesday announced the start of Phase III trial of its COVID-19 vaccine in India.
-
India Reaches Out To US Companies Over Investment In Pharma Sector
India has reached out to top American pharma companies seeking investment in the country's pharmaceutical and medical devices sector, which gains urgency in view of a devastating second wave of the coronavirus pandemic.
-
"UK Marks A Historic Moment In Fight Against Covid-19": Pfizer CEO
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
Snowflake IPO Raises $3.36 Billion in Year's Biggest US Listing
Snowflake said that its initial public offering raised $3.36 billion (roughly Rs. 24,711 crores) after it was priced above the target range in the biggest US listing so far this year.
-
US Pharma Firm Gilead To Make 2 Million Courses Of Remdesivir By 2020 End
Gilead Sciences Inc is planning to make more than two million courses of its potential COVID-19 drug remdesivir by the end of the year and start trials of an easier-to-use inhaled version in August, the company said on Monday.
-
US Company Signs $87 Million Coronavirus Vaccine Deal With UK Pharma Firm
Emergent BioSolutions Inc said on Thursday it signed an $87 million deal to make AstraZeneca Plc's experimental COVID-19 vaccine in the United States, boosting the British drugmaker's efforts to bring a vaccine to the market.
-
US Pharma Firm Says Its COVID-19 Vaccine Produces Antibodies In Mice, Guinea Pigs
US immunotherapy company Inovio Pharmaceuticals Inc on Wednesday said its experimental vaccine to prevent coronavirus infection was shown to produce protective antibodies and immune system responses in mice and guinea pigs.
